Kelly Shi
Stock Analyst at Jefferies
(0.92)
# 2,906
Out of 4,479 analysts
21
Total ratings
30%
Success rate
-15.76%
Average return
Main Sectors:
Top Industries:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals | Initiates: Buy | $37 | $21.53 | +71.85% | 1 | Jun 28, 2024 | |
| PROK ProKidney | Maintains: Buy | $15 → $6 | $2.50 | +140.00% | 2 | Jun 10, 2024 | |
| PTCT PTC Therapeutics | Maintains: Buy | $35 → $46 | $31.17 | +47.58% | 3 | May 20, 2024 | |
| TIL Instil Bio | Downgrades: Hold | $5 → $11 | $10.30 | +6.80% | 1 | Apr 12, 2024 | |
| INCY Incyte | Initiates: Buy | $81 | $60.87 | +33.07% | 1 | Feb 23, 2024 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $35 | $18.15 | +92.84% | 1 | Feb 20, 2024 | |
| CABA Cabaletta Bio | Initiates: Buy | $36 | $7.81 | +360.95% | 1 | Feb 5, 2024 | |
| ASND Ascendis Pharma | Initiates: Buy | $150 | $133.98 | +11.96% | 1 | Dec 20, 2023 | |
| CNTA Centessa Pharmaceuticals | Upgrades: Buy | $4 → $11 | $8.80 | +25.00% | 1 | Nov 15, 2023 | |
| BGNE BeiGene | Initiates: Buy | $287 | $144.89 | +98.08% | 1 | Aug 17, 2023 | |
| MLTX MoonLake Immunotherapeutics | Initiates: Buy | $16 | $41.80 | -61.72% | 1 | Nov 11, 2022 | |
| KYMR Kymera Therapeutics | Initiates: Buy | $40 | $30.95 | +29.24% | 1 | Aug 15, 2022 | |
| GLUE Monte Rosa Therapeutics | Initiates: Buy | $20 | $3.94 | +407.61% | 1 | Aug 15, 2022 | |
| IBRX ImmunityBio | Initiates: Buy | $8 | $6.27 | +27.59% | 1 | Aug 3, 2022 | |
| ACET Adicet Bio | Initiates: Buy | $27 | $1.15 | +2,247.83% | 1 | Mar 4, 2022 | |
| HCM HUTCHMED (China) | Initiates: Buy | n/a | $17.56 | - | 1 | Aug 3, 2021 | |
| CNTB Connect Biopharma Holdings | Initiates: Buy | n/a | $1.44 | - | 1 | Apr 13, 2021 | |
| ADAG Adagene | Initiates: Buy | n/a | $3.05 | - | 1 | Mar 8, 2021 |
Syndax Pharmaceuticals
Jun 28, 2024
Initiates: Buy
Price Target: $37
Current: $21.53
Upside: +71.85%
ProKidney
Jun 10, 2024
Maintains: Buy
Price Target: $15 → $6
Current: $2.50
Upside: +140.00%
PTC Therapeutics
May 20, 2024
Maintains: Buy
Price Target: $35 → $46
Current: $31.17
Upside: +47.58%
Instil Bio
Apr 12, 2024
Downgrades: Hold
Price Target: $5 → $11
Current: $10.30
Upside: +6.80%
Incyte
Feb 23, 2024
Initiates: Buy
Price Target: $81
Current: $60.87
Upside: +33.07%
ArriVent BioPharma
Feb 20, 2024
Initiates: Buy
Price Target: $35
Current: $18.15
Upside: +92.84%
Cabaletta Bio
Feb 5, 2024
Initiates: Buy
Price Target: $36
Current: $7.81
Upside: +360.95%
Ascendis Pharma
Dec 20, 2023
Initiates: Buy
Price Target: $150
Current: $133.98
Upside: +11.96%
Centessa Pharmaceuticals
Nov 15, 2023
Upgrades: Buy
Price Target: $4 → $11
Current: $8.80
Upside: +25.00%
BeiGene
Aug 17, 2023
Initiates: Buy
Price Target: $287
Current: $144.89
Upside: +98.08%
MoonLake Immunotherapeutics
Nov 11, 2022
Initiates: Buy
Price Target: $16
Current: $41.80
Upside: -61.72%
Kymera Therapeutics
Aug 15, 2022
Initiates: Buy
Price Target: $40
Current: $30.95
Upside: +29.24%
Monte Rosa Therapeutics
Aug 15, 2022
Initiates: Buy
Price Target: $20
Current: $3.94
Upside: +407.61%
ImmunityBio
Aug 3, 2022
Initiates: Buy
Price Target: $8
Current: $6.27
Upside: +27.59%
Adicet Bio
Mar 4, 2022
Initiates: Buy
Price Target: $27
Current: $1.15
Upside: +2,247.83%
HUTCHMED (China)
Aug 3, 2021
Initiates: Buy
Price Target: n/a
Current: $17.56
Upside: -
Connect Biopharma Holdings
Apr 13, 2021
Initiates: Buy
Price Target: n/a
Current: $1.44
Upside: -
Adagene
Mar 8, 2021
Initiates: Buy
Price Target: n/a
Current: $3.05
Upside: -